Retraction

EFFICACY, SAFETY, AND TOLERABILITY OF OMILANCOR IN A PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF PATIENTS WITH ULCERATIVE COLITIS

Paper Information

Record ID:
37213
Publication Date:
January 20, 2022
Retraction Date:
March 15, 2022 (3.7 years years ago)
Subjects:
Institutions:
Countries:
Unknown
Publisher:
Elsevier
Open Access:
Yes
PubMed ID:
Not indexed in PubMed
Retraction PubMed ID:
Not indexed in PubMed

Retraction Details

Nature of Retraction:

Retraction

Citations (1)

1
Total Citations
0
Post-Retraction
0
Pre-Retraction
0
Same Day
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Quick Stats
Total Citations: 1
Years Since Retraction: 3.7 years
Open Access: Yes
Last Checked: Jul 24, 2025
Related Papers
A Phase III Head-to-Head Study to Compare the Efficacy and …
Journal of Clinical Medicine • 4 citations
Effect of Compound Polyethylene Glycol Electrolyte Powder o…
Emergency Medicine International • 4 citations
Cisapride versus Maren Pill for Functional Constipation: A …
Evidence-Based Complementary and Alternative Medicine • 2 citations